Global immunosuppressants API market is expected to grow at a formidable rate during the forecast period predominantly on account of continuous technological advancements in tissue engineering. Moreover, surging incidence of autoimmune disorders such as multiple sclerosis, alopecia areata and arthritis is positively impacting the growth of market. Also, increase in organ transplants such as liver & kidney transplants worldwide are further expected to bolster the growth of market over the next few years. However, certain factors that can act as major impediments to the growth of global immunosuppressants API market in the forthcoming years include high costs associated with API and lack of availability of organ donors.

The global immunosuppressants API market is segmented based on method, application, type, product, APIs, end user, and region. Based on product, the market can be categorized into tablets, capsules, liquids and injections; out of which, the tablet segment dominated the market and is expected to maintain its leading position during the forecast period as well, majorly on account of their longer shelf life coupled with cost-effective manufacturing process. Additionally, they can accommodate a higher dose of active ingredient as compared to capsules, which is further expected to boost the segmental growth over the coming years. In terms of application, the market is fragmented into autoimmune disease and organ transplant. The autoimmune disease segment held the largest market share until 2019 and is forecast to register higher growth during the forecast period, which is attributable to growing prevalence of autoimmune diseases across the globe. Based on end user, the market is categorized into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs, and Others. Among them, the biotechnology & biopharmaceutical companies segment is projected to dominate the market over the next five years, on account of rising investments for research and developmental activities. 

Major players operating in the global immunosuppressants API market include Biocon Ltd., NATCO Pharma Limited, Triveni Interchem Private Limited, Concord Biotech Ltd., RPG Life Sciences Limited, Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd, Chunghwa Chemical Synthesis & Biotech Co. Ltd., AbbVie Inc., Pfizer Inc., Zhejiang Hisun Pharmaceutical Co. Ltd. among others. Leading market players are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, collaborations, partnership, and agreements to increase customer base and expand geographic reach.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of global immunosuppressants API market from 2015 to 2018.
  • To estimate and forecast the market size of global immunosuppressants API market from 2019 to 2025.
  • To classify and forecast global immunosuppressants API market based on method, application, type, product, APIs, end user, and regional distribution.
  • To identify dominant region or segment in the global immunosuppressants API market.
  • To identify drivers and challenges for global immunosuppressants API market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global immunosuppressants API market.
  • To conduct pricing analysis for global immunosuppressants API market.
  • To identify and analyze the profile of leading players operating in global immunosuppressants API market.
  • to identify key sustainable strategies adopted by market players in global immunosuppressants API market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the companies and presence of all major players operating across the globe.

TechSci Research calculated the market size of global immunosuppressants API market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Immunosuppressants API companies
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to immunosuppressants API
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global immunosuppressants API market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • By Method:
    • Synthetic Chemistry
    • Peptide chemistry
    • Fermentation
    • Chromatographic purification
  • By Application:
    • Autoimmune Disease
    • Organ Transplant
  • By Type:
    • Corticosteroids
    • Janus kinase inhibitor
    • Calcineurin inhibitors
    • mTOR inhibitor
    • IMDH inhibitor
    • Biologics
    • Monoclonal antibodies
  • By Product:
    • Tablets
    • Capsules
    • Liquids
    • Injections
  • By APIs:
    • Tacrolimus
    • Sirolimus
    • Everolimus
    • Mycophenolate Mofetil
    • Mycophenolate Sodium
  • By End User:
    • Biotechnology & Biopharmaceutical Companies
    • CMOs
    • CROs
    • CDMOs
    • Others
  • By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global immunosuppressants API market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Immunosuppressants API market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Immunosuppressants API Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Immunosuppressants API Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Method (Synthetic Chemistry, Peptide chemistry, Fermentation, Chromatographic purification)

6.2.2.     By Application (Autoimmune Disease, Organ Transplant)

6.2.3.     By Type (Corticosteroids, Janus kinase inhibitor, Calcineurin inhibitors, mTOR inhibitor, IMDH inhibitor, Biologics, Monoclonal antibodies)

6.2.4.     By Product (Tablets, Capsules, Liquids, Injections)

6.2.5.     By APIs (Tacrolimus, Sirolimus, Everolimus, Mycophenolate Mofetil (MMF), Mycophenolate Sodium (MPA))

6.2.6.     By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)

6.2.7.     By Company (2019)

6.2.8.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Immunosuppressants API Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Method

7.2.2.     By Application

7.2.3.     By Type

7.2.4.     By Product

7.2.5.     By APIs

7.2.6.     By End User

7.2.7.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Immunosuppressants API Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Method

7.3.1.2.2.             By Application

7.3.1.2.3.             By Type

7.3.1.2.4.             By Product

7.3.1.2.5.             By APIs

7.3.1.2.6.             By End User

7.3.2.     India Immunosuppressants API Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Method

7.3.2.2.2.             By Application

7.3.2.2.3.             By Type

7.3.2.2.4.             By Product

7.3.2.2.5.             By APIs

7.3.2.2.6.             By End User

7.3.3.     Australia Immunosuppressants API Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Method

7.3.3.2.2.             By Application

7.3.3.2.3.             By Type

7.3.3.2.4.             By Product

7.3.3.2.5.             By APIs

7.3.3.2.6.             By End User

7.3.4.     Japan Immunosuppressants API Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Method

7.3.4.2.2.             By Application

7.3.4.2.3.             By Type

7.3.4.2.4.             By Product

7.3.4.2.5.             By APIs

7.3.4.2.6.             By End User

7.3.5.     South Korea Immunosuppressants API Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Method

7.3.5.2.2.             By Application

7.3.5.2.3.             By Type

7.3.5.2.4.             By Product

7.3.5.2.5.             By APIs

7.3.5.2.6.             By End User

8.    Europe Immunosuppressants API Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Method

8.2.2.     By Application

8.2.3.     By Type

8.2.4.     By Product

8.2.5.     By APIs

8.2.6.     By End User

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Immunosuppressants API Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Method

8.3.1.2.2.             By Application

8.3.1.2.3.             By Type

8.3.1.2.4.             By Product

8.3.1.2.5.             By APIs

8.3.1.2.6.             By End User

8.3.2.     Germany Immunosuppressants API Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Method

8.3.2.2.2.             By Application

8.3.2.2.3.             By Type

8.3.2.2.4.             By Product

8.3.2.2.5.             By APIs

8.3.2.2.6.             By End User

8.3.3.     United Kingdom Immunosuppressants API Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Method

8.3.3.2.2.             By Application

8.3.3.2.3.             By Type

8.3.3.2.4.             By Product

8.3.3.2.5.             By APIs

8.3.3.2.6.             By End User

8.3.4.     Italy Immunosuppressants API Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Method

8.3.4.2.2.             By Application

8.3.4.2.3.             By Type

8.3.4.2.4.             By Product

8.3.4.2.5.             By APIs

8.3.4.2.6.             By End User

8.3.5.     Spain Immunosuppressants API Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Method

8.3.5.2.2.             By Application

8.3.5.2.3.             By Type

8.3.5.2.4.             By Product

8.3.5.2.5.             By APIs

8.3.5.2.6.             By End User

9.    North America Immunosuppressants API Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Method

9.2.2.     By Application

9.2.3.     By Type

9.2.4.     By Product

9.2.5.     By APIs

9.2.6.     By End User

9.2.7.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Immunosuppressants API Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Method

9.3.1.2.2.             By Application

9.3.1.2.3.             By Type

9.3.1.2.4.             By Product

9.3.1.2.5.             By APIs

9.3.1.2.6.             By End User

9.3.2.     Mexico Immunosuppressants API Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Method

9.3.2.2.2.             By Application

9.3.2.2.3.             By Type

9.3.2.2.4.             By Product

9.3.2.2.5.             By APIs

9.3.2.2.6.             By End User

9.3.3.     Canada Immunosuppressants API Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Method

9.3.3.2.2.             By Application

9.3.3.2.3.             By Type

9.3.3.2.4.             By Product

9.3.3.2.5.             By APIs

9.3.3.2.6.             By End User

10.  South America Immunosuppressants API Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Method

10.2.2.  By Application

10.2.3.  By Type

10.2.4.  By Product

10.2.5.  By APIs

10.2.6.  By End User

10.2.7.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Immunosuppressants API Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Method

10.3.1.2.2.           By Application

10.3.1.2.3.           By Type

10.3.1.2.4.           By Product

10.3.1.2.5.           By APIs

10.3.1.2.6.           By End User

10.3.2.  Argentina Immunosuppressants API Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Method

10.3.2.2.2.           By Application

10.3.2.2.3.           By Type

10.3.2.2.4.           By Product

10.3.2.2.5.           By APIs

10.3.2.2.6.           By End User

10.3.3.  Colombia Immunosuppressants API Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Method

10.3.3.2.2.           By Application

10.3.3.2.3.           By Type

10.3.3.2.4.           By Product

10.3.3.2.5.           By APIs

10.3.3.2.6.           By End User

11.  Middle East and Africa Immunosuppressants API Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product Type

11.2.2.  By Source

11.2.3.  By Method

11.2.4.  By Technology

11.2.5.  By Application

11.2.6.  By End User

11.2.7.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Immunosuppressants API Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Method

11.3.1.2.2.           By Application

11.3.1.2.3.           By Type

11.3.1.2.4.           By Product

11.3.1.2.5.           By APIs

11.3.1.2.6.           By End User

11.3.2.  Saudi Arabia Immunosuppressants API Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Method

11.3.2.2.2.           By Application

11.3.2.2.3.           By Type

11.3.2.2.4.           By Product

11.3.2.2.5.           By APIs

11.3.2.2.6.           By End User

11.3.3.  UAE Immunosuppressants API Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Method

11.3.3.2.2.           By Application

11.3.3.2.3.           By Type

11.3.3.2.4.           By Product

11.3.3.2.5.           By APIs

11.3.3.2.6.           By End User

11.3.4.  Kuwait Immunosuppressants API Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Method

11.3.4.2.2.           By Application

11.3.4.2.3.           By Type

11.3.4.2.4.           By Product

11.3.4.2.5.           By APIs

11.3.4.2.6.           By End User

12.  Market Dynamics

12.1.   Drivers

12.2.   Challenges

13.  Market Trends & Developments

14.  Patent Analysis

15.  Competitive Landscape

15.1.   Competition Outlook

15.2.   Players Profiled (Leading Companies)

15.2.1.  Biocon Ltd.

15.2.2.  NATCO Pharma Limited

15.2.3.  Triveni Interchem Private Limited

15.2.4.  Concord Biotech Ltd.

15.2.5.  RPG Life Sciences Limited

15.2.6.  Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd

15.2.7.  Chunghwa Chemical Synthesis & Biotech Co. Ltd.

15.2.8.  AbbVie Inc.

15.2.9.  Pfizer Inc.

15.2.10. Zhejiang Hisun Pharmaceutical Co Ltd

Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com